Analysts cut ratings on multiple stocks
Evercore, Morgan Stanley, Raymond James, Citi, TD Cowen, RBC and UBS issued lower or neutral ratings on ALGN, AN, GPI, HUBS, ICE, MOS and OI.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
22 results loaded, newest first. End of these results.
Rentokil falls after Morgan Stanley downgrades rating to equal weight
Morgan Stanley downgraded Rentokil to “equal weight” from “overweight” and trimmed its price target to 420p from 500p. Shares were down 2.4% at 297.1p, with the stock down 33.6% year-to-date.
Microsoft, 3M, Twilio feature in U.S. stocks on the move
Reuters lists notable U.S. stock movers, including Microsoft, 3M and Twilio, in choppy trading. The item also highlights several other gainers and losers across the major U.S. exchanges.
BUZZ — U.S. STOCKS ON THE MOVEx — Microsoft, Nike, Nektar Therapeutics
Workspace search string for individual stock moves: STXBZ The Day Ahead newsletter: The Morning News Call newsletter: September 25 (Reuters) — Wall Street's main indexes inched higher in choppy trading on Friday as AI optimism buoyed sentiment and oil prices eased, while investors monitored efforts to secure a deal to
Morgan Stanley downgrades Ericsson to underweight on margins and AI gap
Morgan Stanley downgraded Ericsson to “underweight” from “equal-weight”, citing shrinking North American revenue, falling margins, and Ericsson’s lack of direct AI exposure versus peers. The broker cut its PT by 5% to SEK 90 and expects lower earnings, projecting flat RAN demand as telcos stay conservative on mobile ca
Morgan Stanley Downgrades Novo Nordisk to Sell on Lilly Competition
Novo Nordisk A/S (NVO, Financials), the Danish drugmaker behind Wegovy and Ozempic, is facing a problem that may arrive well before its patent cliff.Morgan Stanley downgraded the stock to Sell after its latest survey suggested Eli Lilly could keep taking share in the fast-growing obesity and diabet…
Morgan Stanley downgrades Novo Nordisk to Underweight
Morgan Stanley cut its rating on Novo Nordisk, citing ongoing concern over semaglutide’s loss of exclusivity overhang. Shares were down more than 1% premarket.
Morgan Stanley downgrades Central Bancompany to equal-weight
Morgan Stanley cut Central Bancompany from overweight to equal-weight, according to Benzinga ratings actions.
Morgan Stanley cuts European telecoms, tobacco and paper to lower ratings
Morgan Stanley downgraded European Telecoms to Equal Weight from Overweight, European Paper and Packaging to Underweight from Equal Weight, and European Tobacco to Equal Weight from Overweight.
Morgan Stanley changes European sector ratings across utilities, chemicals, retail
Morgan Stanley downgraded the European utilities sector to equal weight from overweight, and raised European chemicals and European discretionary retail sectors to equal weight from underweight.
Morgan Stanley cuts LILA to Underweight, sets $7.00 target
Morgan Stanley downgrades LILA to Underweight from Equalweight and assigns a $7.00 price target.
Morgan Stanley downgrades Lila Sciences to Underweight, sets $7 target
Morgan Stanley downgrades LILA from Equal Weight to Underweight and sets a $7 price target.
Baidu downgraded to Underweight, Morgan Stanley cuts PT to $80
Morgan Stanley downgrades BIDU to Underweight from Equalweight and lowers its price target to $80 from $130.
Morgan Stanley Downgrades FRPT
Morgan Stanley downgrades FRPT to Equal Weight
Morgan Stanley Downgrades W
W downgraded to Underweight
NFLX Netflix is another drag on the market, with shares down more than 11% after the streaming giant's in-line results for the second quarte
NFLX Netflix is another drag on the market, with shares down more than 11% after the streaming giant's in-line results for the second quarter and a disappointing outlook. No major analyst downgrades, but a bunch of price target decreases: Goldman Sachs to $94 from $110; UBS to $115 from $130; JPMorgan to $85 from $118;
This M&T Bank Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Jefferies analyst David Chiaverini downgraded Huntington Bancshares Inc (NASDAQ: HBAN ) from Buy to Hold and lowered
Robinhood Markets shares are trading higher after Mizuho maintained an Outperform rating on the stock and raised its price target from $115
Robinhood Markets shares are trading higher after Mizuho maintained an Outperform rating on the stock and raised its price target from $115 to $130.
Goldman Sachs Maintains Neutral on Brown & Brown, Raises Price Target to $70
Goldman Sachs analyst Robert Cox maintains Brown & Brown (NYSE: BRO ) with a Neutral and raises the price target from $62 to $70.
This Talos Energy Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Roth Capital analyst Leo Mariani upgraded Talos Energy Inc (NYSE: TALO ) from Neutral to Buy and raised the price tar
Analysts Raise Targets
Top Wall Street analysts raise price targets for several stocks including Okta, International Seaways, and Ralliant
MU Price Target Raised
Needham raises Micron Technology price target from $500 to $1,550 and maintains Buy rating